pharma · Aplastic Anemia · Advanced Hepatocellular Carcinoma
Kyowa Kirin International
KYOWA KIRIN AUSTRALIA PTY LTD
Kyowa Kirin International clinical programs — 6 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- GB
- Founded
- 1995
- Employees
- 690
- Programs
- 15
- Drugs
- 12
- Patents
- 0
Kyowa Kirin International projects
6 ClinicalTrials.gov programs sponsored by Kyowa Kirin International.
Kyowa Kirin International has 6 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
AMG531
KYOWA KIRIN AUSTRALIA PTY LTD
Aplastic Anemia
1 trial -
Entinostat
KYOWA KIRIN AUSTRALIA PTY LTD
Advanced or Recurrent Breast Cancer
1 trial -
KHK7580
KYOWA KIRIN AUSTRALIA PTY LTD
Hyperparathyroidism
1 trial -
KW-2478
KYOWA KIRIN AUSTRALIA PTY LTD
Multiple Myeloma
1 trial -
POTELIGEO 4 mg/mL concentrate for solution for infusion
KYOWA KIRIN AUSTRALIA PTY LTD
Mycosis fungoides/Sezary syndrome recurrent
1 trial -
saxagliptin
KYOWA KIRIN AUSTRALIA PTY LTD
Diabetes, Type 2
1 trial
Frequently asked questions
How many clinical projects does Kyowa Kirin International have?
6 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.